Drug Profile
AMG 581
Latest Information Update: 28 Sep 2018
Price :
$50
*
At a glance
- Originator Amgen
- Class Antipsychotics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Schizoaffective disorder; Schizophrenia
Most Recent Events
- 28 Sep 2018 No recent reports of development identified for phase-I development in Schizoaffective-disorder in USA (PO)
- 28 Mar 2018 No recent reports of development identified for phase-I development in Schizophrenia in USA (PO)
- 24 Jul 2015 Amgen plans a phase I study for Schizophrenia in USA (NCT02504476)